SENECA CAPITAL ADVISORS LLC Insider Trading Activity

Average Profitability
<0.0001%
Insider Buys Quantity
0
Insider Buys Sum
$0
Insider Sells Quantity
15
Insider Sells Sum
$832,816.00

Insider Activity of SENECA CAPITAL ADVISORS LLC

Biography of SENECA CAPITAL ADVISORS LLC

No biography is available at this moment.

2003-07-31SaleEloxx Pharmaceuticals, Inc.
ELOX
10 percent owner
200,000
1.6738%
$2.18$436,000+46.59%
2003-06-24SaleEloxx Pharmaceuticals, Inc.
ELOX
10 percent owner
10,800
0.0831%
$2.05$22,140+44.44%
2003-06-23SaleEloxx Pharmaceuticals, Inc.
ELOX
10 percent owner
14,200
0.1251%
$2.40$34,080+40.22%
2003-05-06SaleEloxx Pharmaceuticals, Inc.
ELOX
10 percent owner
600
0.0051%
$2.03$1,218+52.5%
2003-04-22SaleEloxx Pharmaceuticals, Inc.
ELOX
10 percent owner
10,000
0.0845%
$1.99$19,900+51.76%
2003-04-21SaleEloxx Pharmaceuticals, Inc.
ELOX
10 percent owner
24,500
0.2129%
$2.15$52,675+44.5%
2003-04-15SaleEloxx Pharmaceuticals, Inc.
ELOX
10 percent owner
8,000
0.0632%
$2.05$16,400+37.44%
2003-04-14SaleEloxx Pharmaceuticals, Inc.
ELOX
10 percent owner
15,000
0.1261%
$2.00$30,000+49.75%
2003-04-11SaleEloxx Pharmaceuticals, Inc.
ELOX
10 percent owner
9,200
0.0777%
$2.00$18,400+51%
2003-04-04SaleEloxx Pharmaceuticals, Inc.
ELOX
10 percent owner
50,000
0.4033%
$1.91$95,500+50%
2002-11-05SaleEloxx Pharmaceuticals, Inc.
ELOX
10 percent owner
28,500
0.2598%
$2.59$73,815-0.83%
2002-11-04SaleEloxx Pharmaceuticals, Inc.
ELOX
10 percent owner
1,000
0.0087%
$2.02$2,020+23.08%
2002-10-07SaleEloxx Pharmaceuticals, Inc.
ELOX
10 percent owner
10,000
0.105%
$1.99$19,900+46.25%
2002-10-02SaleEloxx Pharmaceuticals, Inc.
ELOX
10 percent owner
5,000
0.0448%
$1.91$9,550+30%
2002-09-30SaleEloxx Pharmaceuticals, Inc.
ELOX
10 percent owner
600
0.0054%
$2.03$1,218+23.16%
Total: 15
Company
About Prismo.proIdeasArticlesPrivacy PolicyTerms of ServiceContact Us
Screener Ideas
Dividend StocksBlue Chip StocksDefensive StocksGrowth StocksValue StocksCyclical StocksPenny Stocks
Stock Tools
Insiders ScreenerStocks ScreenerTop StocksStock NewsInsider RatioList of All Stocks
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.